Bausch Health Companies Inc. Revenues
Bausch Health Companies Inc. (BHC) reported Revenues of $2.00 billion for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2018-08-10
- Bausch Health Companies Inc. revenues for the quarter ending 2018-03-31 was $2.00B, a 5.41% decline year-over-year.
- Bausch Health Companies Inc. revenues for the quarter ending 2017-12-31 was $2.16B, a 9.99% decline year-over-year.
- Bausch Health Companies Inc. revenues for the quarter ending 2017-09-30 was $2.22B, a 10.49% decline year-over-year.
- Bausch Health Companies Inc. revenues for the quarter ending 2017-06-30 was $2.23B, a 7.73% decline year-over-year.
- Bausch Health Companies Inc. revenues for fiscal 2014 was $8.21B, a 42.23% increase from fiscal 2013.
- Bausch Health Companies Inc. revenues for fiscal 2013 was $5.77B, a 65.77% increase from fiscal 2012.
- Bausch Health Companies Inc. revenues for fiscal 2012 was $3.48B, a 43.38% increase from fiscal 2011.
- Bausch Health Companies Inc. revenues for fiscal 2011 was $2.43B, a 105.50% increase from fiscal 2010.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $2.00B 10-Q · filed 2018-05-08 | $4.16B derived: sum of 2 quarters · filed 2018-08-10 | $6.38B derived: sum of 3 quarters · filed 2018-08-10 | $8.61B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-12-31 | $2.16B 8-K · filed 2018-08-10 | $4.38B derived: sum of 2 quarters · filed 2018-08-10 | $6.62B derived: sum of 3 quarters · filed 2018-08-10 | $8.72B 8-K · filed 2018-08-10 | ||||
| 2017-09-30 | $2.22B 8-K · filed 2018-08-10 | $4.45B derived: sum of 2 quarters · filed 2018-08-10 | $6.56B 10-Q · filed 2017-11-07 | $8.96B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-06-30 | $2.23B 8-K · filed 2018-08-10 | $4.34B 10-Q · filed 2017-08-08 | $6.75B derived: sum of 3 quarters · filed 2018-08-10 | $9.22B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $2.11B 8-K · filed 2018-08-10 | $4.51B derived: sum of 2 quarters · filed 2018-08-10 | $6.99B derived: sum of 3 quarters · filed 2018-08-10 | $9.41B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2016-12-31 | $2.40B 8-K · filed 2018-08-10 | $4.88B derived: sum of 2 quarters · filed 2018-08-10 | $7.30B derived: sum of 3 quarters · filed 2018-08-10 | $9.67B 8-K · filed 2018-08-10 | ||||
| 2016-09-30 | $2.48B 8-K · filed 2018-08-10 | $2.48B 10-Q · filed 2016-11-09 | $4.90B derived: sum of 2 quarters · filed 2018-08-10 | $7.27B 10-Q · filed 2017-11-07 | $7.27B 10-Q · filed 2016-11-09 | $10.03B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | $2.42B 8-K · filed 2018-08-10 | $2.42B 10-Q · filed 2016-08-09 | $4.79B 10-Q · filed 2017-08-08 | $4.79B 10-Q · filed 2016-08-09 | $7.55B derived: sum of 3 quarters · filed 2018-08-10 | $10.34B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | $2.37B 8-K · filed 2018-08-10 | $2.37B 10-Q · filed 2016-06-07 | $5.13B derived: sum of 2 quarters · filed 2018-08-10 | $7.92B derived: sum of 3 quarters · filed 2018-08-10 | $10.65B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $2.76B 10-K · filed 2017-03-01 | $2.76B 10-K · filed 2016-04-29 | $5.54B derived: sum of 2 quarters · filed 2017-03-01 | $8.28B derived: sum of 3 quarters · filed 2017-03-01 | $10.45B 8-K · filed 2018-08-10 | $10.45B 10-K · filed 2016-04-29 | ||
| 2015-09-30 | $2.79B 10-K · filed 2017-03-01 | $2.79B 10-Q · filed 2015-10-26 | $5.52B derived: sum of 2 quarters · filed 2017-03-01 | $7.69B 10-Q · filed 2016-11-09 | $7.71B 10-Q · filed 2015-10-26 | $9.92B derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-06-30 | $2.73B 10-K · filed 2017-03-01 | $2.73B 10-Q · filed 2015-07-28 | $4.90B 10-Q · filed 2016-08-09 | $4.92B 10-Q · filed 2015-07-28 | $7.14B derived: sum of 3 quarters · filed 2017-03-01 | $9.18B derived: sum of 4 quarters · filed 2017-03-01 | ||
| 2015-03-31 | $2.17B 10-K · filed 2017-03-01 | $2.19B 10-Q · filed 2015-04-30 | $4.40B derived: sum of 2 quarters · filed 2017-03-01 | $6.45B derived: sum of 3 quarters · filed 2017-03-01 | $8.49B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $2.24B 10-K · filed 2016-04-29 | $4.28B derived: sum of 2 quarters · filed 2016-04-29 | $6.32B derived: sum of 3 quarters · filed 2016-04-29 | $8.21B 10-K · filed 2017-03-01 | $8.26B 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $2.04B 10-K · filed 2016-04-29 | $2.06B 10-Q · filed 2014-10-24 | $4.08B derived: sum of 2 quarters · filed 2016-04-29 | $5.97B 10-K · filed 2016-04-29 | $5.98B 10-Q · filed 2014-10-24 | $8.03B derived: sum of 4 quarters · filed 2016-04-29 | ||
| 2014-06-30 | $2.04B 10-K · filed 2016-04-29 | $3.93B 10-K · filed 2016-04-29 | $5.99B derived: sum of 3 quarters · filed 2016-04-29 | $7.53B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $1.89B 10-K · filed 2016-04-29 | $3.95B derived: sum of 2 quarters · filed 2016-04-29 | $5.49B derived: sum of 3 quarters · filed 2016-04-29 | $6.59B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $2.06B derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $3.61B derived: sum of 2 quarters · filed 2016-04-29 | $4.70B derived: sum of 3 quarters · filed 2016-04-29 | $5.77B 10-K · filed 2016-04-29 | $5.77B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $1.54B 10-Q · filed 2014-10-24 | $1.54B 10-Q · filed 2013-11-01 | $2.64B derived: sum of 2 quarters · filed 2014-10-24 | $3.71B 10-Q · filed 2014-10-24 | $3.71B 10-Q · filed 2013-11-01 | $4.63B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $1.10B 10-Q · filed 2014-08-01 | $1.10B 10-Q · filed 2013-08-07 | $2.16B 10-Q · filed 2014-08-01 | $2.16B 10-Q · filed 2013-08-07 | $3.08B derived: sum of 3 quarters · filed 2015-02-25 | $3.97B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $1.07B 10-Q · filed 2014-05-09 | $1.07B 10-Q · filed 2013-05-03 | $1.99B derived: sum of 2 quarters · filed 2015-02-25 | $2.87B derived: sum of 3 quarters · filed 2015-02-25 | $3.69B derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $920.07M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $1.80B derived: sum of 2 quarters · filed 2015-02-25 | $2.62B derived: sum of 3 quarters · filed 2015-02-25 | $3.48B 10-K · filed 2015-02-25 | $3.55B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $884.14M 10-Q · filed 2013-11-01 | $1.70B derived: sum of 2 quarters · filed 2013-11-01 | $2.56B 10-Q · filed 2013-11-01 | $3.21B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | $820.09M 10-Q · filed 2013-08-07 | $1.68B 10-Q · filed 2013-08-07 | $2.33B derived: sum of 3 quarters · filed 2014-02-28 | $2.93B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $856.10M 10-Q · filed 2013-05-03 | $1.51B derived: sum of 2 quarters · filed 2014-02-28 | $2.11B derived: sum of 3 quarters · filed 2014-02-28 | $2.72B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $652.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $1.25B derived: sum of 2 quarters · filed 2014-02-28 | $1.86B derived: sum of 3 quarters · filed 2014-02-28 | $2.43B 10-K · filed 2014-02-28 | $2.46B 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $600.58M 10-Q · filed 2012-11-05 | $1.21B derived: sum of 2 quarters · filed 2012-11-05 | $1.77B 10-Q · filed 2012-11-05 | $2.29B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $609.39M 10-Q · filed 2012-08-03 | $1.17B 10-Q · filed 2012-08-03 | $1.69B derived: sum of 3 quarters · filed 2013-02-28 | $1.90B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $565.03M 10-Q · filed 2012-05-04 | $1.08B derived: sum of 2 quarters · filed 2013-02-28 | $1.29B derived: sum of 3 quarters · filed 2013-02-28 | $1.53B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $514.56M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $722.83M derived: sum of 2 quarters · filed 2013-02-28 | $961.60M derived: sum of 3 quarters · filed 2013-02-28 | $1.18B 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $208.27M 10-Q · filed 2011-11-04 | $447.04M derived: sum of 2 quarters · filed 2011-11-04 | $666.67M 10-Q · filed 2011-11-04 | $907.73M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $238.77M 10-Q · filed 2011-08-08 | $458.41M 10-Q · filed 2011-08-08 | $699.46M derived: sum of 3 quarters · filed 2012-02-29 | $911.98M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $219.63M 10-Q · filed 2011-05-10 | $460.69M derived: sum of 2 quarters · filed 2012-02-29 | $673.21M derived: sum of 3 quarters · filed 2012-02-29 | $866.75M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $241.05M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $453.58M derived: sum of 2 quarters · filed 2012-02-29 | $647.11M derived: sum of 3 quarters · filed 2012-02-29 | $820.43M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $212.52M 10-Q · filed 2010-11-05 | $406.06M derived: sum of 2 quarters · filed 2010-11-05 | $579.38M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $193.53M 10-Q · filed 2010-08-06 | $366.85M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $757.18M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |